<?xml version="1.0" encoding="UTF-8"?>
<hmdb xmlns="http://www.hmdb.ca">
   <metabolite>
      <version>4.0</version>
      <creation_date>2005-11-16 15:48:42 UTC</creation_date>
      <update_date>2018-05-20 20:24:02 UTC</update_date>
      <accession>HMDB0000001</accession>
      <status>quantified</status>
      <secondary_accessions>
         <accession>HMDB00001</accession>
         <accession>HMDB0004935</accession>
         <accession>HMDB0006703</accession>
         <accession>HMDB0006704</accession>
         <accession>HMDB04935</accession>
         <accession>HMDB06703</accession>
         <accession>HMDB06704</accession>
      </secondary_accessions>
      <name>1-Methylhistidine</name>
      <cs_description>1-Methylhistidine, also known as 1-mhis, belongs to the class of organic compounds known as histidine and derivatives. Histidine and derivatives are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. 1-Methylhistidine has been found in human muscle and skeletal muscle tissues, and has also been detected in most biofluids, including cerebrospinal fluid, saliva, blood, and feces. Within the cell, 1-methylhistidine is primarily located in the cytoplasm. 1-Methylhistidine participates in a number of enzymatic reactions. In particular, 1-Methylhistidine and Beta-alanine can be converted into anserine; which is catalyzed by the enzyme carnosine synthase 1. In addition, Beta-Alanine and 1-methylhistidine can be biosynthesized from anserine; which is mediated by the enzyme cytosolic non-specific dipeptidase. In humans, 1-methylhistidine is involved in the histidine metabolism pathway. 1-Methylhistidine is also involved in the metabolic disorder called the histidinemia pathway.</cs_description>
      <description>One-methylhistidine (1-MHis) is derived mainly from the anserine of dietary flesh sources, especially poultry. The enzyme, carnosinase, splits anserine into b-alanine and 1-MHis. High levels of 1-MHis tend to inhibit the enzyme carnosinase and increase anserine levels. Conversely, genetic variants with deficient carnosinase activity in plasma show increased 1-MHis excretions when they consume a high meat diet. Reduced serum carnosinase activity is also found in patients with Parkinson's disease and multiple sclerosis and patients following a cerebrovascular accident. Vitamin E deficiency can lead to 1-methylhistidinuria from increased oxidative effects in skeletal muscle. 1-Methylhistidine is a biomarker for the consumption of meat, especially red meat.</description>
      <synonyms>
         <synonym>(2S)-2-amino-3-(1-Methyl-1H-imidazol-4-yl)propanoic acid</synonym>
         <synonym>1-Methylhistidine</synonym>
         <synonym>Pi-methylhistidine</synonym>
         <synonym>(2S)-2-amino-3-(1-Methyl-1H-imidazol-4-yl)propanoate</synonym>
         <synonym>1 Methylhistidine</synonym>
         <synonym>1-Methyl histidine</synonym>
         <synonym>1-Methyl-histidine</synonym>
         <synonym>1-Methyl-L-histidine</synonym>
         <synonym>1-MHis</synonym>
         <synonym>1-N-Methyl-L-histidine</synonym>
         <synonym>L-1-Methylhistidine</synonym>
         <synonym>N1-Methyl-L-histidine</synonym>
         <synonym>1-Methylhistidine dihydrochloride</synonym>
      </synonyms>
      <chemical_formula>C7H11N3O2</chemical_formula>
      <average_molecular_weight>169.1811</average_molecular_weight>
      <monisotopic_molecular_weight>169.085126611</monisotopic_molecular_weight>
      <iupac_name>(2S)-2-amino-3-(1-methyl-1H-imidazol-4-yl)propanoic acid</iupac_name>
      <traditional_iupac>1 methylhistidine</traditional_iupac>
      <cas_registry_number>332-80-9</cas_registry_number>
      <smiles>CN1C=NC(C[C@H](N)C(O)=O)=C1</smiles>
      <inchi>InChI=1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11)12/h3-4,6H,2,8H2,1H3,(H,11,12)/t6-/m0/s1</inchi>
      <inchikey>BRMWTNUJHUMWMS-LURJTMIESA-N</inchikey>
      <taxonomy>
         <description>This compound belongs to the class of organic compounds known as histidine and derivatives. These are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.</description>
         <direct_parent>Histidine and derivatives</direct_parent>
         <kingdom>Organic compounds</kingdom>
         <super_class>Organic acids and derivatives</super_class>
         <class>Carboxylic acids and derivatives</class>
         <sub_class>Amino acids, peptides, and analogues</sub_class>
         <molecular_framework>Aromatic heteromonocyclic compounds</molecular_framework>
         <alternative_parents>
            <alternative_parent>Amino acids</alternative_parent>
            <alternative_parent>Aralkylamines</alternative_parent>
            <alternative_parent>Azacyclic compounds</alternative_parent>
            <alternative_parent>Carbonyl compounds</alternative_parent>
            <alternative_parent>Carboxylic acids</alternative_parent>
            <alternative_parent>Heteroaromatic compounds</alternative_parent>
            <alternative_parent>Hydrocarbon derivatives</alternative_parent>
            <alternative_parent>Imidazolyl carboxylic acids and derivatives</alternative_parent>
            <alternative_parent>L-alpha-amino acids</alternative_parent>
            <alternative_parent>Monoalkylamines</alternative_parent>
            <alternative_parent>Monocarboxylic acids and derivatives</alternative_parent>
            <alternative_parent>N-substituted imidazoles</alternative_parent>
            <alternative_parent>Organic oxides</alternative_parent>
            <alternative_parent>Organopnictogen compounds</alternative_parent>
         </alternative_parents>
         <substituents>
            <substituent>Alpha-amino acid</substituent>
            <substituent>Amine</substituent>
            <substituent>Amino acid</substituent>
            <substituent>Aralkylamine</substituent>
            <substituent>Aromatic heteromonocyclic compound</substituent>
            <substituent>Azacycle</substituent>
            <substituent>Azole</substituent>
            <substituent>Carbonyl group</substituent>
            <substituent>Carboxylic acid</substituent>
            <substituent>Heteroaromatic compound</substituent>
            <substituent>Histidine or derivatives</substituent>
            <substituent>Hydrocarbon derivative</substituent>
            <substituent>Imidazole</substituent>
            <substituent>Imidazolyl carboxylic acid derivative</substituent>
            <substituent>L-alpha-amino acid</substituent>
            <substituent>Monocarboxylic acid or derivatives</substituent>
            <substituent>N-substituted imidazole</substituent>
            <substituent>Organic nitrogen compound</substituent>
            <substituent>Organic oxide</substituent>
            <substituent>Organic oxygen compound</substituent>
            <substituent>Organoheterocyclic compound</substituent>
            <substituent>Organonitrogen compound</substituent>
            <substituent>Organooxygen compound</substituent>
            <substituent>Organopnictogen compound</substituent>
            <substituent>Primary aliphatic amine</substituent>
            <substituent>Primary amine</substituent>
         </substituents>
         <external_descriptors>
            <external_descriptor>L-histidine derivative</external_descriptor>
            <external_descriptor>non-proteinogenic L-alpha-amino acid</external_descriptor>
         </external_descriptors>
      </taxonomy>
      <ontology>
         <root>
            <term>Physiological effect</term>
            <definition>The effect on an organism physiology, resulting from its exposure to a chemical.</definition>
            <parent_id />
            <level>1</level>
            <type>parent</type>
            <descendants>
               <descendant>
                  <term>Health effect</term>
                  <definition>A health condition or observation associated with a stimuli or with a biological activity of a chemical.</definition>
                  <parent_id>7693</parent_id>
                  <level>2</level>
                  <type>parent</type>
                  <synonyms />
                  <descendants>
                     <descendant>
                        <term>Health condition</term>
                        <definition>A health effect that consists on short or long-term disease, condition, disorder, syndrome or constant abnormality.</definition>
                        <parent_id>7694</parent_id>
                        <level>3</level>
                        <type>parent</type>
                        <synonyms />
                        <descendants>
                           <descendant>
                              <term>Kidney disease</term>
                              <definition>A urinary system disease that is located in the kidney. (do).</definition>
                              <parent_id>7695</parent_id>
                              <level>4</level>
                              <type>child</type>
                              <synonyms>
                                 <synonym>Renal disease</synonym>
                                 <synonym>Nephropathy</synonym>
                              </synonyms>
                           </descendant>
                           <descendant>
                              <term>Diabetes mellitus type 2</term>
                              <definition />
                              <parent_id>7695</parent_id>
                              <level>4</level>
                              <type>child</type>
                              <synonyms>
                                 <synonym>Non-insulin-dependent diabetes mellitus</synonym>
                                 <synonym>Niddm</synonym>
                                 <synonym>Adult-onset diabetes</synonym>
                              </synonyms>
                           </descendant>
                           <descendant>
                              <term>Metabolism and nutrition disorders</term>
                              <definition>A group of disorders, inherited or not, that result in a metabolic malfunction.</definition>
                              <parent_id>7695</parent_id>
                              <level>4</level>
                              <type>parent</type>
                              <synonyms />
                              <descendants>
                                 <descendant>
                                    <term>Obesity</term>
                                    <definition>A disorder characterized by having a high amount of body fat. (nci ctcae).</definition>
                                    <parent_id>7708</parent_id>
                                    <level>5</level>
                                    <type>child</type>
                                    <synonyms />
                                 </descendant>
                              </descendants>
                           </descendant>
                        </descendants>
                     </descendant>
                  </descendants>
               </descendant>
            </descendants>
         </root>
         <root>
            <term>Disposition</term>
            <definition>A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.</definition>
            <parent_id />
            <level>1</level>
            <type>parent</type>
            <descendants>
               <descendant>
                  <term>Source</term>
                  <definition>Natural or synthetic origin of a chemical.</definition>
                  <parent_id>7724</parent_id>
                  <level>2</level>
                  <type>parent</type>
                  <synonyms />
                  <descendants>
                     <descendant>
                        <term>Endogenous</term>
                        <definition />
                        <parent_id>7735</parent_id>
                        <level>3</level>
                        <type>child</type>
                        <synonyms />
                     </descendant>
                  </descendants>
               </descendant>
               <descendant>
                  <term>Biological location</term>
                  <definition>The physiological origin within an organism, including anatomical compnents, biofluids and excreta.</definition>
                  <parent_id>7724</parent_id>
                  <level>2</level>
                  <type>parent</type>
                  <synonyms />
                  <descendants>
                     <descendant>
                        <term>Tissue and substructures</term>
                        <definition>An anatomical organizational level including multiple cells yet not comprising a complete organ .</definition>
                        <parent_id>7725</parent_id>
                        <level>3</level>
                        <type>parent</type>
                        <synonyms />
                        <descendants>
                           <descendant>
                              <term>Muscle</term>
                              <definition>A fibrous soft tissue with the ability to contract to produce force and motion. (nci).</definition>
                              <parent_id>7729</parent_id>
                              <level>4</level>
                              <type>child</type>
                              <synonyms />
                           </descendant>
                           <descendant>
                              <term>Skeletal muscle</term>
                              <definition>Striated muscles that are under voluntary control of the organism. they are connected at either or both ends to a bone and are utilized for locomotion and other movements. (nci).</definition>
                              <parent_id>7729</parent_id>
                              <level>4</level>
                              <type>child</type>
                              <synonyms>
                                 <synonym>Striated muscle</synonym>
                              </synonyms>
                           </descendant>
                        </descendants>
                     </descendant>
                     <descendant>
                        <term>Biofluid and excreta</term>
                        <definition>A liquid, semi-solid or solid material originating in the body.</definition>
                        <parent_id>7725</parent_id>
                        <level>3</level>
                        <type>parent</type>
                        <synonyms />
                        <descendants>
                           <descendant>
                              <term>Saliva</term>
                              <definition>The watery fluid in the mouth made by the salivary glands. saliva moistens food to help digestion and it helps protect the mouth against infections. (nci).</definition>
                              <parent_id>7731</parent_id>
                              <level>4</level>
                              <type>child</type>
                              <synonyms />
                           </descendant>
                           <descendant>
                              <term>Feces</term>
                              <definition>The material discharged from the bowel during defecation. It consists of undigested food, intestinal mucus, epithelial cells, and bacteria.</definition>
                              <parent_id>7731</parent_id>
                              <level>4</level>
                              <type>child</type>
                              <synonyms>
                                 <synonym>Fecal</synonym>
                                 <synonym>Stool</synonym>
                                 <synonym>Faecal</synonym>
                                 <synonym>Faeces</synonym>
                              </synonyms>
                           </descendant>
                           <descendant>
                              <term>Urine</term>
                              <definition>Excretion in liquid state processed by the kidney.</definition>
                              <parent_id>7731</parent_id>
                              <level>4</level>
                              <type>child</type>
                              <synonyms />
                           </descendant>
                           <descendant>
                              <term>Blood</term>
                              <definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</definition>
                              <parent_id>7731</parent_id>
                              <level>4</level>
                              <type>child</type>
                              <synonyms />
                           </descendant>
                           <descendant>
                              <term>Cerebrospinal fluid</term>
                              <definition>The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord. (nci).</definition>
                              <parent_id>7731</parent_id>
                              <level>4</level>
                              <type>child</type>
                              <synonyms>
                                 <synonym>Csf</synonym>
                              </synonyms>
                           </descendant>
                        </descendants>
                     </descendant>
                     <descendant>
                        <term>Subcellular</term>
                        <definition>An anatomical organizational level including a component within a biological cell .</definition>
                        <parent_id>7725</parent_id>
                        <level>3</level>
                        <type>parent</type>
                        <synonyms />
                        <descendants>
                           <descendant>
                              <term>Cytoplasm</term>
                              <definition>The portion of the cell contained within the plasma membrane but excluding the nucleus.</definition>
                              <parent_id>7730</parent_id>
                              <level>4</level>
                              <type>child</type>
                              <synonyms>
                                 <synonym>Cytoplasma</synonym>
                              </synonyms>
                           </descendant>
                        </descendants>
                     </descendant>
                  </descendants>
               </descendant>
            </descendants>
         </root>
         <root>
            <term>Process</term>
            <definition>Biological or chemical events, or a series thereof, leading to a known function or end-product.</definition>
            <parent_id />
            <level>1</level>
            <type>parent</type>
            <descendants>
               <descendant>
                  <term>Naturally occurring process</term>
                  <definition>Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.</definition>
                  <parent_id>7659</parent_id>
                  <level>2</level>
                  <type>parent</type>
                  <synonyms />
                  <descendants>
                     <descendant>
                        <term>Biological process</term>
                        <definition>Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.</definition>
                        <parent_id>7660</parent_id>
                        <level>3</level>
                        <type>parent</type>
                        <synonyms />
                        <descendants>
                           <descendant>
                              <term>Biochemical pathway</term>
                              <definition>A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.</definition>
                              <parent_id>7661</parent_id>
                              <level>4</level>
                              <type>parent</type>
                              <synonyms />
                              <descendants>
                                 <descendant>
                                    <term>Histidine Metabolism</term>
                                    <definition>after reaching several years of age, humans begin to synthesize it (most likely in the intestinal micrflora) and it thus becomes a non-essential amino acid. humans can obtain histidine through the breakdown of carnosine (a dipeptide containing histidine and beta-alanine) via the action of carnosine dipeptidase.</definition>
                                    <parent_id>7662</parent_id>
                                    <level>5</level>
                                    <type>child</type>
                                    <synonyms />
                                 </descendant>
                              </descendants>
                           </descendant>
                        </descendants>
                     </descendant>
                  </descendants>
               </descendant>
            </descendants>
         </root>
         <root>
            <term>Role</term>
            <definition>The purpose or function assumed by a chemical, either naturally or as intended by humans .</definition>
            <parent_id />
            <level>1</level>
            <type>parent</type>
            <descendants>
               <descendant>
                  <term>Industrial application</term>
                  <definition>The assumed function of a chemical utilized by human.</definition>
                  <parent_id>7671</parent_id>
                  <level>2</level>
                  <type>parent</type>
                  <synonyms />
                  <descendants>
                     <descendant>
                        <term>Pharmaceutical industry</term>
                        <definition>A pharmacologic activity for which a chemical substance is utilized owing to its biological role.</definition>
                        <parent_id>7678</parent_id>
                        <level>3</level>
                        <type>parent</type>
                        <synonyms />
                        <descendants>
                           <descendant>
                              <term>Pharmaceutical</term>
                              <definition />
                              <parent_id>7679</parent_id>
                              <level>4</level>
                              <type>child</type>
                              <synonyms />
                           </descendant>
                        </descendants>
                     </descendant>
                  </descendants>
               </descendant>
            </descendants>
         </root>
      </ontology>
      <state>Solid</state>
      <experimental_properties>
         <property>
            <kind>melting_point</kind>
            <value>249</value>
            <source>http://download.cappchem.com/data/Properties-of-Amino-Acids.pdf</source>
         </property>
      </experimental_properties>
      <predicted_properties>
         <property>
            <kind>solubility</kind>
            <value>6.93 g/L</value>
            <source>ALOGPS</source>
         </property>
         <property>
            <kind>logp</kind>
            <value>-3.1</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>pka_strongest_acidic</kind>
            <value>1.96</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>pka_strongest_basic</kind>
            <value>9.25</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>iupac</kind>
            <value>(2S)-2-amino-3-(1-methyl-1H-imidazol-4-yl)propanoic acid</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>average_mass</kind>
            <value>169.1811</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>mono_mass</kind>
            <value>169.085126611</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>smiles</kind>
            <value>CN1C=NC(C[C@H](N)C(O)=O)=C1</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>formula</kind>
            <value>C7H11N3O2</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>inchi</kind>
            <value>InChI=1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11)12/h3-4,6H,2,8H2,1H3,(H,11,12)/t6-/m0/s1</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>inchikey</kind>
            <value>BRMWTNUJHUMWMS-LURJTMIESA-N</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>polar_surface_area</kind>
            <value>81.14</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>refractivity</kind>
            <value>42.39</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>polarizability</kind>
            <value>17.11</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>rotatable_bond_count</kind>
            <value>3</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>acceptor_count</kind>
            <value>4</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>donor_count</kind>
            <value>2</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>physiological_charge</kind>
            <value>0</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>formal_charge</kind>
            <value>0</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>number_of_rings</kind>
            <value>1</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>bioavailability</kind>
            <value>1</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>rule_of_five</kind>
            <value>Yes</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>ghose_filter</kind>
            <value>Yes</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>veber_rule</kind>
            <value>Yes</value>
            <source>ChemAxon</source>
         </property>
         <property>
            <kind>mddr_like_rule</kind>
            <value>Yes</value>
            <source>ChemAxon</source>
         </property>
      </predicted_properties>
      <spectra>
         <spectrum>
            <type>Specdb::CMs</type>
            <spectrum_id>1469</spectrum_id>
         </spectrum>
         <spectrum>
            <type>Specdb::CMs</type>
            <spectrum_id>1755</spectrum_id>
         </spectrum>
         <spectrum>
            <type>Specdb::CMs</type>
            <spectrum_id>7663</spectrum_id>
         </spectrum>
         <spectrum>
            <type>Specdb::CMs</type>
            <spectrum_id>30940</spectrum_id>
         </spectrum>
         <spectrum>
            <type>Specdb::CMs</type>
            <spectrum_id>30941</spectrum_id>
         </spectrum>
         <spectrum>
            <type>Specdb::CMs</type>
            <spectrum_id>37237</spectrum_id>
         </spectrum>
         <spectrum>
            <type>Specdb::NmrOneD</type>
            <spectrum_id>1022</spectrum_id>
         </spectrum>
         <spectrum>
            <type>Specdb::MsMs</type>
            <spectrum_id>1</spectrum_id>
         </spectrum>
         <spectrum>
            <type>Specdb::MsMs</type>
            <spectrum_id>2</spectrum_id>
         </spectrum>
         <spectrum>
            <type>Specdb::MsMs</type>
            <spectrum_id>3</spectrum_id>
         </spectrum>
         <spectrum>
            <type>Specdb::MsMs</type>
            <spectrum_id>255159</spectrum_id>
         </spectrum>
         <spectrum>
            <type>Specdb::MsMs</type>
            <spectrum_id>255160</spectrum_id>
         </spectrum>
         <spectrum>
            <type>Specdb::MsMs</type>
            <spectrum_id>255161</spectrum_id>
         </spectrum>
         <spectrum>
            <type>Specdb::MsMs</type>
            <spectrum_id>275100</spectrum_id>
         </spectrum>
         <spectrum>
            <type>Specdb::MsMs</type>
            <spectrum_id>275101</spectrum_id>
         </spectrum>
         <spectrum>
            <type>Specdb::MsMs</type>
            <spectrum_id>275102</spectrum_id>
         </spectrum>
         <spectrum>
            <type>Specdb::NmrTwoD</type>
            <spectrum_id>915</spectrum_id>
         </spectrum>
      </spectra>
      <cellular_locations>
         <cellular>Cytoplasm</cellular>
      </cellular_locations>
      <biospecimen_locations>
         <biospecimen>Blood</biospecimen>
         <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
         <biospecimen>Feces</biospecimen>
         <biospecimen>Saliva</biospecimen>
         <biospecimen>Urine</biospecimen>
      </biospecimen_locations>
      <tissue_locations>
         <tissue>Muscle</tissue>
         <tissue>Skeletal Muscle</tissue>
      </tissue_locations>
      <pathways>
         <pathway>
            <name>Histidine Metabolism</name>
            <smpdb_id>SMP00044</smpdb_id>
            <kegg_map_id>map00340</kegg_map_id>
         </pathway>
         <pathway>
            <name>Histidinemia</name>
            <smpdb_id>SMP00191</smpdb_id>
            <kegg_map_id />
         </pathway>
      </pathways>
      <normal_concentrations>
         <concentration>
            <biospecimen>Blood</biospecimen>
            <concentration_value>7.7 +/- 1.9</concentration_value>
            <concentration_units>uM</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Both</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>Dohm GL, Williams RT, Kasperek GJ, van Rij AM: Increased excretion of urea and N tau -methylhistidine by rats and humans after a bout of exercise. J Appl Physiol Respir Environ Exerc Physiol. 1982 Jan;52(1):27-33.</reference_text>
                  <pubmed_id>7061274</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Blood</biospecimen>
            <concentration_value>14.4 +/- 2.3</concentration_value>
            <concentration_units>uM</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Both</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>Dohm GL, Williams RT, Kasperek GJ, van Rij AM: Increased excretion of urea and N tau -methylhistidine by rats and humans after a bout of exercise. J Appl Physiol Respir Environ Exerc Physiol. 1982 Jan;52(1):27-33.</reference_text>
                  <pubmed_id>7061274</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Blood</biospecimen>
            <concentration_value>19.6 +/- 2.6</concentration_value>
            <concentration_units>uM</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Both</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>Dohm GL, Williams RT, Kasperek GJ, van Rij AM: Increased excretion of urea and N tau -methylhistidine by rats and humans after a bout of exercise. J Appl Physiol Respir Environ Exerc Physiol. 1982 Jan;52(1):27-33.</reference_text>
                  <pubmed_id>7061274</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Blood</biospecimen>
            <concentration_value>12.7 +/- 2.9</concentration_value>
            <concentration_units>uM</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Both</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>Dohm GL, Williams RT, Kasperek GJ, van Rij AM: Increased excretion of urea and N tau -methylhistidine by rats and humans after a bout of exercise. J Appl Physiol Respir Environ Exerc Physiol. 1982 Jan;52(1):27-33.</reference_text>
                  <pubmed_id>7061274</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Blood</biospecimen>
            <concentration_value>20.2 +/- 4.0</concentration_value>
            <concentration_units>uM</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Both</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>Dohm GL, Williams RT, Kasperek GJ, van Rij AM: Increased excretion of urea and N tau -methylhistidine by rats and humans after a bout of exercise. J Appl Physiol Respir Environ Exerc Physiol. 1982 Jan;52(1):27-33.</reference_text>
                  <pubmed_id>7061274</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Blood</biospecimen>
            <concentration_value>9.1 +/- 7.2</concentration_value>
            <concentration_units>uM</concentration_units>
            <subject_age>Children (1-13 years old)</subject_age>
            <subject_sex>Not Specified</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 85-97. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
                  <pubmed_id />
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Blood</biospecimen>
            <concentration_value>4.0 +/- 8.0</concentration_value>
            <concentration_units>uM</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Both</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 85-97. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
                  <pubmed_id />
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
            <concentration_value>4.0 +/- 1.74</concentration_value>
            <concentration_units>uM</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Both</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
                  <pubmed_id>17031479</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Feces</biospecimen>
            <concentration_value />
            <concentration_units />
            <subject_age>Not Specified</subject_age>
            <subject_sex>Both</subject_sex>
            <subject_condition>Normal</subject_condition>
            <comment>By CIL LCâˆ’MS</comment>
            <references>
               <reference>
                  <reference_text>Xu W, Chen D, Wang N, Zhang T, Zhou R, Huan T, Lu Y, Su X, Xie Q, Li L, Li L: Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome. Anal Chem. 2015 Jan 20;87(2):829-36. doi: 10.1021/ac503619q. Epub 2014 Dec 25.</reference_text>
                  <pubmed_id>25486321</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Feces</biospecimen>
            <concentration_value />
            <concentration_units />
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Both</subject_sex>
            <subject_condition>Normal</subject_condition>
            <comment>Lyophilized feces samples (n=18) were used in the study.  Instrument: LC-MS. Technology specification: UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
            <references>
               <reference>
                  <reference_text>Loftfield E, Vogtmann E, Sampson JN, Moore SC, Nelson H, Knight R, Chia N, Sinha R: Comparison of Collection Methods for Fecal Samples for Discovery Metabolomics in Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1483-1490. doi: 10.1158/1055-9965.EPI-16-0409. Epub 2016 Aug 19.</reference_text>
                  <pubmed_id>27543620</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Saliva</biospecimen>
            <concentration_value>26.34</concentration_value>
            <concentration_units>uM</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Both</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>Vranic L, Granic P, Rajic Z: Basic amino acid in the pathogenesis of caries. Acta Stomatol Croat. 1991;25(2):71-6.</reference_text>
                  <pubmed_id>1819935</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>10-17</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Female</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>Husek P, Svagera Z, Hanzlikova D, Rimnacova L, Zahradnickova H, Opekarova I, Simek P: Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry. J Chromatogr A. 2016 Apr 22;1443:211-32. doi: 10.1016/j.chroma.2016.03.019. Epub  2016 Mar 10.</reference_text>
                  <pubmed_id>27012787</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value />
            <concentration_units />
            <subject_age />
            <subject_sex>Male</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>Jacobs DM, Spiesser L, Garnier M, de Roo N, van Dorsten F, Hollebrands B, van Velzen E, Draijer R, van Duynhoven J: SPE-NMR metabolite sub-profiling of urine. Anal Bioanal Chem. 2012 Nov;404(8):2349-61. doi: 10.1007/s00216-012-6339-2. Epub  2012 Aug 31.</reference_text>
                  <pubmed_id>22932811</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>17.74-153.77</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Both</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>David F. Putnam Composition and Concentrative Properties of Human Urine. NASA Contractor Report. July 1971</reference_text>
                  <pubmed_id />
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>8.3 (2.4-28.4)</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Both</subject_sex>
            <subject_condition>Normal</subject_condition>
            <comment>urine by NMR</comment>
            <references>
               <reference>
                  <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
                  <pubmed_id>24023812</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>15.9 +/- 19.5</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Female</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
                  <pubmed_id>11052553</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>46.0833 +/- 53.432</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Female</subject_sex>
            <subject_condition>Normal</subject_condition>
            <comment>Blacks - Omnivores. From Exposome Explorer.</comment>
            <references>
               <reference>
                  <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
                  <pubmed_id>11052553</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>11-16</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Male</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>Husek P, Svagera Z, Hanzlikova D, Rimnacova L, Zahradnickova H, Opekarova I, Simek P: Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry. J Chromatogr A. 2016 Apr 22;1443:211-32. doi: 10.1016/j.chroma.2016.03.019. Epub  2016 Mar 10.</reference_text>
                  <pubmed_id>27012787</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>45.473 +/- 41.617</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Male</subject_sex>
            <subject_condition>Normal</subject_condition>
            <comment>Blacks - Omnivores. From Exposome Explorer.</comment>
            <references>
               <reference>
                  <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
                  <pubmed_id>11052553</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>15.919 +/- 19.503</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Female</subject_sex>
            <subject_condition>Normal</subject_condition>
            <comment>Blacks - Vegetarians. From Exposome Explorer.</comment>
            <references>
               <reference>
                  <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
                  <pubmed_id>11052553</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>4.635</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Male</subject_sex>
            <subject_condition>Normal</subject_condition>
            <comment>Blacks - Vegetarians. From Exposome Explorer.</comment>
            <references>
               <reference>
                  <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
                  <pubmed_id>11052553</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>33.624 +/- 36.360</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Female</subject_sex>
            <subject_condition>Normal</subject_condition>
            <comment>Whites - Omnivores. From Exposome Explorer.</comment>
            <references>
               <reference>
                  <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
                  <pubmed_id>11052553</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>28.0954 +/- 31.826</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Male</subject_sex>
            <subject_condition>Normal</subject_condition>
            <comment>Whites - Omnivores. From Exposome Explorer.</comment>
            <references>
               <reference>
                  <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
                  <pubmed_id>11052553</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>2.340 +/- 5.0764</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Female</subject_sex>
            <subject_condition>Normal</subject_condition>
            <comment>Whites - Vegetarians. From Exposome Explorer.</comment>
            <references>
               <reference>
                  <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
                  <pubmed_id>11052553</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>1.334 +/- 2.759</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Male</subject_sex>
            <subject_condition>Normal</subject_condition>
            <comment>Whites - Vegetarians. From Exposome Explorer.</comment>
            <references>
               <reference>
                  <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
                  <pubmed_id>11052553</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>30.0 +/- 43.0</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Both</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
                  <pubmed_id>15899597</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>4.6 +/- 2.7</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Male</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
                  <pubmed_id>11052553</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>2.3 +/- 5.1</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Female</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
                  <pubmed_id>11052553</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>46.1 +/- 53.5</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Female</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
                  <pubmed_id>11052553</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>15.9 +/- 19.5</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Female</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
                  <pubmed_id>11052553</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>28.1 +/- 31.8</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Male</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
                  <pubmed_id>11052553</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>1.3 +/- 2.76</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Male</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
                  <pubmed_id>11052553</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>45.5 +/- 41.6</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Male</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
                  <pubmed_id>11052553</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>33.6 +/- 36.4</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Female</subject_sex>
            <subject_condition>Normal</subject_condition>
            <references>
               <reference>
                  <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
                  <pubmed_id>11052553</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>21.329 +/- 12.971</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <subject_age>Children (1 - 13 years old)</subject_age>
            <subject_sex>Not Specified</subject_sex>
            <subject_condition>Normal</subject_condition>
            <comment>By NMR</comment>
            <references>
               <reference>
                  <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
                  <pubmed_id />
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value />
            <concentration_units />
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Male</subject_sex>
            <subject_condition>Normal</subject_condition>
            <comment>Under omnivorous diet</comment>
            <references>
               <reference>
                  <reference_text>Stella C, Beckwith-Hall B, Cloarec O, Holmes E, Lindon JC, Powell J, van der Ouderaa F, Bingham S, Cross AJ, Nicholson JK: Susceptibility of human metabolic phenotypes to dietary modulation. J Proteome Res. 2006 Oct;5(10):2780-8.</reference_text>
                  <pubmed_id>17022649</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value />
            <concentration_units />
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Both</subject_sex>
            <subject_condition>Normal</subject_condition>
            <comment>With fish (Salmon) consumption</comment>
            <references>
               <reference>
                  <reference_text>Lloyd AJ, Beckmann M, Fave G, Mathers JC, Draper J: Proline betaine and its biotransformation products in fasting urine samples are potential biomarkers of habitual citrus fruit consumption. Br J Nutr. 2011 Sep;106(6):812-24. doi: 10.1017/S0007114511001164. Epub 2011 May  9.</reference_text>
                  <pubmed_id>21736852</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value />
            <concentration_units />
            <subject_age>Adult (&gt;18 years old)</subject_age>
            <subject_sex>Both</subject_sex>
            <subject_condition>Normal</subject_condition>
            <comment>Healthy condition not specified, assume it is healthy</comment>
            <references>
               <reference>
                  <reference_text>Lloyd AJ, Beckmann M, Haldar S, Seal C, Brandt K, Draper J: Data-driven strategy for the discovery of potential urinary biomarkers of habitual dietary exposure. Am J Clin Nutr. 2013 Feb;97(2):377-89. doi: 10.3945/ajcn.112.048033. Epub 2012 Dec 26.</reference_text>
                  <pubmed_id>23269817</pubmed_id>
               </reference>
            </references>
         </concentration>
      </normal_concentrations>
      <abnormal_concentrations>
         <concentration>
            <biospecimen>Blood</biospecimen>
            <concentration_value>51.2 +/- 17.6</concentration_value>
            <concentration_units>uM</concentration_units>
            <patient_age>Adult (&gt;18 years old)</patient_age>
            <patient_sex>Female</patient_sex>
            <patient_information>Pregnancy with fetuses with trisomy 18</patient_information>
            <comment>Pregnancies between 11 weeks and 13 weeks 6 daysÃ¢â‚¬â„¢ gestation with fetuses with trisomy 18</comment>
            <references>
               <reference>
                  <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
                  <pubmed_id>23535240</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Blood</biospecimen>
            <concentration_value>43.4 +/- 22.3</concentration_value>
            <concentration_units>uM</concentration_units>
            <patient_age>Adult (&gt;18 years old)</patient_age>
            <patient_sex>Female</patient_sex>
            <patient_information>Pregnancy</patient_information>
            <references>
               <reference>
                  <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
                  <pubmed_id>23535240</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Blood</biospecimen>
            <concentration_value>50.7 (12.9)</concentration_value>
            <concentration_units>uM</concentration_units>
            <patient_age>Adult (&gt;18 years old)</patient_age>
            <patient_sex>Female</patient_sex>
            <patient_information>Early preeclampsia</patient_information>
            <references>
               <reference>
                  <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
                  <pubmed_id>22494326</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Blood</biospecimen>
            <concentration_value>50.0 (14.6)</concentration_value>
            <concentration_units>uM</concentration_units>
            <patient_age>Adult (&gt;18 years old)</patient_age>
            <patient_sex>Female</patient_sex>
            <patient_information>Pregnancy</patient_information>
            <references>
               <reference>
                  <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
                  <pubmed_id>22494326</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Blood</biospecimen>
            <concentration_value>28.8 +/- 18.2</concentration_value>
            <concentration_units>uM</concentration_units>
            <patient_age>Adult (&gt;18 years old)</patient_age>
            <patient_sex>Both</patient_sex>
            <patient_information>Kidney disease</patient_information>
            <comment>Patients with chronic renal failure on maintenance hemodialysis. These subjects were treated with nocturnal hemodialysis for 8 h during the night, 6 times/week.</comment>
            <references>
               <reference>
                  <reference_text>Raj DS, Ouwendyk M, Francoeur R, Pierratos A: Plasma amino acid profile on nocturnal hemodialysis. Blood Purif. 2000;18(2):97-102.</reference_text>
                  <pubmed_id>10838467</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Blood</biospecimen>
            <concentration_value>83.1 +/- 21.7</concentration_value>
            <concentration_units>uM</concentration_units>
            <patient_age>Adult (&gt;18 years old)</patient_age>
            <patient_sex>Both</patient_sex>
            <patient_information>Kidney disease</patient_information>
            <comment>Patients with chronic renal failure on maintenance hemodialysis. These subjects were treated with conventional hemodialysis for 4 h, 3 times/week.</comment>
            <references>
               <reference>
                  <reference_text>Raj DS, Ouwendyk M, Francoeur R, Pierratos A: Plasma amino acid profile on nocturnal hemodialysis. Blood Purif. 2000;18(2):97-102.</reference_text>
                  <pubmed_id>10838467</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Blood</biospecimen>
            <concentration_value>70.3 (40.0)</concentration_value>
            <concentration_units>uM</concentration_units>
            <patient_age>Adult (&gt;18 years old)</patient_age>
            <patient_sex>Female</patient_sex>
            <patient_information>Late-onset preeclampsia</patient_information>
            <references>
               <reference>
                  <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
                  <pubmed_id>23159745</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Blood</biospecimen>
            <concentration_value>38.9 (20.3)</concentration_value>
            <concentration_units>uM</concentration_units>
            <patient_age>Adult (&gt;18 years old)</patient_age>
            <patient_sex>Female</patient_sex>
            <patient_information>Pregnancy</patient_information>
            <references>
               <reference>
                  <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
                  <pubmed_id>23159745</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Blood</biospecimen>
            <concentration_value>10.66 +/- 2.68</concentration_value>
            <concentration_units>uM</concentration_units>
            <patient_age>Elderly (&gt;65 years old)</patient_age>
            <patient_sex>Both</patient_sex>
            <patient_information>Alzheimer's disease</patient_information>
            <comment>Probable Alzheimer's disease</comment>
            <references>
               <reference>
                  <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
                  <pubmed_id>17031479</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Blood</biospecimen>
            <concentration_value>40.4 (12.3)</concentration_value>
            <concentration_units>uM</concentration_units>
            <patient_age>Adult (&gt;18 years old)</patient_age>
            <patient_sex>Female</patient_sex>
            <patient_information>Down syndrome pregnancy</patient_information>
            <references>
               <reference>
                  <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
                  <pubmed_id>23313728</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Blood</biospecimen>
            <concentration_value>32.7 (13.7)</concentration_value>
            <concentration_units>uM</concentration_units>
            <patient_age>Adult (&gt;18 years old)</patient_age>
            <patient_sex>Female</patient_sex>
            <patient_information>Pregnancy</patient_information>
            <references>
               <reference>
                  <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
                  <pubmed_id>23313728</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
            <concentration_value>2.6 +/- 1.13</concentration_value>
            <concentration_units>uM</concentration_units>
            <patient_age>Adult (&gt;18 years old)</patient_age>
            <patient_sex>Both</patient_sex>
            <patient_information>Alzheimer's disease</patient_information>
            <references>
               <reference>
                  <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
                  <pubmed_id>17031479</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>10.9 +/- 10.1</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <patient_age>Adult (&gt;18 years old)</patient_age>
            <patient_sex>Both</patient_sex>
            <patient_information>Obesity</patient_information>
            <references>
               <reference>
                  <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
                  <pubmed_id>15899597</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>17.5 +/- 25.7</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <patient_age>Adult (&gt;18 years old)</patient_age>
            <patient_sex>Both</patient_sex>
            <patient_information>Diabetes</patient_information>
            <references>
               <reference>
                  <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
                  <pubmed_id>15899597</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>15.7 +/- 4.04</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <patient_age>Adult (&gt;18 years old)</patient_age>
            <patient_sex>Both</patient_sex>
            <patient_information>Alzheimer's disease</patient_information>
            <comment>Probable Alzheimer's disease</comment>
            <references>
               <reference>
                  <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
                  <pubmed_id>17031479</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>18.299 +/- 16.521</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <patient_age>Children (1 - 13 years old)</patient_age>
            <patient_sex>Not Specified</patient_sex>
            <patient_information>Eosinophilic esophagitis</patient_information>
            <comment>By NMR</comment>
            <references>
               <reference>
                  <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
                  <pubmed_id />
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>40 +/- 2.6</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <patient_age>Adult (&gt;18 years old)</patient_age>
            <patient_sex>Both</patient_sex>
            <patient_information>Propionic acidemia</patient_information>
            <references>
               <reference>
                  <reference_text>Gronwald W, Klein MS, Kaspar H, Fagerer SR, Nurnberger N, Dettmer K, Bertsch T, Oefner PJ: Urinary metabolite quantification employing 2D NMR spectroscopy. Anal Chem. 2008 Dec 1;80(23):9288-97. doi: 10.1021/ac801627c.</reference_text>
                  <pubmed_id>19551947</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>31 +/- 11</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <patient_age>Adult (&gt;18 years old)</patient_age>
            <patient_sex>Both</patient_sex>
            <patient_information>Maple syrup urine disease</patient_information>
            <references>
               <reference>
                  <reference_text>Gronwald W, Klein MS, Kaspar H, Fagerer SR, Nurnberger N, Dettmer K, Bertsch T, Oefner PJ: Urinary metabolite quantification employing 2D NMR spectroscopy. Anal Chem. 2008 Dec 1;80(23):9288-97. doi: 10.1021/ac801627c.</reference_text>
                  <pubmed_id>19551947</pubmed_id>
               </reference>
            </references>
         </concentration>
         <concentration>
            <biospecimen>Urine</biospecimen>
            <concentration_value>50.3 +/- 9.9</concentration_value>
            <concentration_units>umol/mmol creatinine</concentration_units>
            <patient_age>Adult (&gt;18 years old)</patient_age>
            <patient_sex>Both</patient_sex>
            <patient_information>Aminoaciduria</patient_information>
            <references>
               <reference>
                  <reference_text>Gronwald W, Klein MS, Kaspar H, Fagerer SR, Nurnberger N, Dettmer K, Bertsch T, Oefner PJ: Urinary metabolite quantification employing 2D NMR spectroscopy. Anal Chem. 2008 Dec 1;80(23):9288-97. doi: 10.1021/ac801627c.</reference_text>
                  <pubmed_id>19551947</pubmed_id>
               </reference>
            </references>
         </concentration>
      </abnormal_concentrations>
      <diseases>
         <disease>
            <name>Alzheimer's disease</name>
            <omim_id>104300</omim_id>
            <references>
               <reference>
                  <reference_text>Redjems-Bennani N, Jeandel C, Lefebvre E, Blain H, Vidailhet M, Gueant JL: Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients. Gerontology. 1998;44(5):300-4.</reference_text>
                  <pubmed_id>9693263</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Raskind MA, Peskind ER, Holmes C, Goldstein DS: Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease. Biol Psychiatry. 1999 Sep 15;46(6):756-65.</reference_text>
                  <pubmed_id>10494443</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Walter A, Korth U, Hilgert M, Hartmann J, Weichel O, Hilgert M, Fassbender K, Schmitt A, Klein J: Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients. Neurobiol Aging. 2004 Nov-Dec;25(10):1299-303.</reference_text>
                  <pubmed_id>15465626</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Selley ML, Close DR, Stern SE: The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease. Neurobiol Aging. 2002 May-Jun;23(3):383-8.</reference_text>
                  <pubmed_id>11959400</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Molina JA, Jimenez-Jimenez FJ, Hernanz A, Fernandez-Vivancos E, Medina S, de Bustos F, Gomez-Escalonilla C, Sayed Y: Cerebrospinal fluid levels of thiamine in patients with Alzheimer's disease. J Neural Transm (Vienna). 2002 Jul;109(7-8):1035-44.</reference_text>
                  <pubmed_id>12111441</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Serot JM, Barbe F, Arning E, Bottiglieri T, Franck P, Montagne P, Nicolas JP: Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2005 Nov;76(11):1585-7.</reference_text>
                  <pubmed_id>16227558</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91.</reference_text>
                  <pubmed_id>15061359</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Lovell MA, Markesbery WR: Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid. Arch Neurol. 2001 Mar;58(3):392-6.</reference_text>
                  <pubmed_id>11255442</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Shetty HU, Holloway HW, Schapiro MB: Cerebrospinal fluid and plasma distribution of myo-inositol and other polyols in Alzheimer disease. Clin Chem. 1996 Feb;42(2):298-302.</reference_text>
                  <pubmed_id>8595727</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Bar KJ, Franke S, Wenda B, Muller S, Kientsch-Engel R, Stein G, Sauer H: Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia. Neurobiol Aging. 2003 Mar-Apr;24(2):333-8.</reference_text>
                  <pubmed_id>12498967</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
                  <pubmed_id>17031479</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Jia JP, Jia JM, Zhou WD, Xu M, Chu CB, Yan X, Sun YX: Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia. Chin Med J (Engl). 2004 Aug;117(8):1161-4.</reference_text>
                  <pubmed_id>15361288</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Reichman ME, Judd JT, Longcope C, Schatzkin A, Clevidence BA, Nair PP, Campbell WS, Taylor PR: Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Inst. 1993 May 5;85(9):722-7.</reference_text>
                  <pubmed_id>8478958</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Abe T, Tohgi H, Isobe C, Murata T, Sato C: Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease. J Neurosci Res. 2002 Nov 1;70(3):447-50.</reference_text>
                  <pubmed_id>12391605</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Molina JA, Jimenez-Jimenez FJ, Aguilar MV, Meseguer I, Mateos-Vega CJ, Gonzalez-Munoz MJ, de Bustos F, Porta J, Orti-Pareja M, Zurdo M, Barrios E, Martinez-Para MC: Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J Neural Transm (Vienna). 1998;105(4-5):479-88.</reference_text>
                  <pubmed_id>9720975</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Bocca B, Forte G, Petrucci F, Pino A, Marchione F, Bomboi G, Senofonte O, Giubilei F, Alimonti A: Monitoring of chemical elements and oxidative damage in patients affected by Alzheimer's disease. Ann Ist Super Sanita. 2005;41(2):197-203.</reference_text>
                  <pubmed_id>16244393</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Kristensen MO, Gulmann NC, Christensen JE, Ostergaard K, Rasmussen K: Serum cobalamin and methylmalonic acid in Alzheimer dementia. Acta Neurol Scand. 1993 Jun;87(6):475-81.</reference_text>
                  <pubmed_id>8356878</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Hozumi I, Hasegawa T, Honda A, Ozawa K, Hayashi Y, Hashimoto K, Yamada M, Koumura A, Sakurai T, Kimura A, Tanaka Y, Satoh M, Inuzuka T: Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J Neurol Sci. 2011 Apr 15;303(1-2):95-9. doi: 10.1016/j.jns.2011.01.003. Epub 2011 Feb 2.</reference_text>
                  <pubmed_id>21292280</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Motawaj M, Peoc'h K, Callebert J, Arrang JM: CSF levels of the histamine metabolite tele-methylhistamine are only slightly decreased in Alzheimer's disease. J Alzheimers Dis. 2010;22(3):861-71. doi: 10.3233/JAD-2010-100381.</reference_text>
                  <pubmed_id>20858978</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Linnebank M, Popp J, Smulders Y, Smith D, Semmler A, Farkas M, Kulic L, Cvetanovska G, Blom H, Stoffel-Wagner B, Kolsch H, Weller M, Jessen F: S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease. Neurodegener Dis. 2010;7(6):373-8. doi: 10.1159/000309657. Epub 2010 Jun 3.</reference_text>
                  <pubmed_id>20523031</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Smach MA, Jacob N, Golmard JL, Charfeddine B, Lammouchi T, Ben Othman L, Dridi H, Bennamou S, Limem K: Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer's disease or dementia: a case control study. Eur Neurol. 2011;65(5):270-8. doi: 10.1159/000326301. Epub 2011 Apr 8.</reference_text>
                  <pubmed_id>21474939</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Rosler N, Wichart I, Jellinger KA: Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients. J Neural Transm (Vienna). 2001;108(2):231-46.</reference_text>
                  <pubmed_id>11314776</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Sunderland T, Berrettini WH, Molchan SE, Lawlor BA, Martinez RA, Vitiello B, Tariot PN, Cohen RM: Reduced cerebrospinal fluid dynorphin A1-8 in Alzheimer's disease. Biol Psychiatry. 1991 Jul 1;30(1):81-7.</reference_text>
                  <pubmed_id>1716470</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
                  <pubmed_id>23857558</pubmed_id>
               </reference>
            </references>
         </disease>
         <disease>
            <name>Pregnancy</name>
            <omim_id />
            <references>
               <reference>
                  <reference_text>Andreolini F, Borra C, Caccamo F, Di Corcia A, Nicoletti I, Samperi R, Improta F: Estriol and its conjugates in late pregnancy determined by extraction with Carbopack B and liquid chromatography with fluorometric detection. Clin Chem. 1985 Oct;31(10):1698-702.</reference_text>
                  <pubmed_id>2994907</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Ball P, Emons G, Haupt O, Hoppen HO, Knuppen R: Radioimmunoassay of 2-hydroxyestrone. Steroids. 1978 Feb;31(2):249-58.</reference_text>
                  <pubmed_id>663967</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Ribar S, Mesaric M, Sedic M: Sphingoid bases as possible diagnostic parameters. Croat Med J. 2003 Apr;44(2):165-70.</reference_text>
                  <pubmed_id>12698507</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Khan HA, Sobki SH, Alhomida AS: Fluctuations in fasting blood glucose and serum fructosamine in pregnant women monitored on successive antenatal visits. Clin Exp Med. 2006 Oct;6(3):134-7.</reference_text>
                  <pubmed_id>17061063</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Yang XL, Wu XR: The dynamic changes of several reproductive hormones during termination of early pregnancy by RU486 in combination with PG-05 in Chinese women. Adv Contracept. 1988 Dec;4(4):319-26.</reference_text>
                  <pubmed_id>3252730</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Yang YJ, Lee J, Choi MH, Chung BC: Direct determination of estriol 3- and 16-glucuronides in pregnancy urine by column-switching liquid chromatography with electrospray tandem mass spectrometry. Biomed Chromatogr. 2003 Jun;17(4):219-25.</reference_text>
                  <pubmed_id>12833386</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Huang PC, Kuo PL, Guo YL, Liao PC, Lee CC: Associations between urinary phthalate monoesters and thyroid hormones in pregnant women. Hum Reprod. 2007 Oct;22(10):2715-22. Epub 2007 Aug 17.</reference_text>
                  <pubmed_id>17704099</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Mikkelsen TB, Osler M, Olsen SF: Validity of protein, retinol, folic acid and n-3 fatty acid intakes estimated from the food-frequency questionnaire used in the Danish National Birth Cohort. Public Health Nutr. 2006 Sep;9(6):771-8.</reference_text>
                  <pubmed_id>16925883</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Shiraishi M, Haruna M, Matsuzaki M, Murayama R, Sasaki S, Murashima S: Validity and reproducibility of folate and vitamin B(12) intakes estimated from a self-administered diet history questionnaire in Japanese pregnant women. Nutr J. 2012 Mar 15;11:15. doi: 10.1186/1475-2891-11-15.</reference_text>
                  <pubmed_id>22420377</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Brantsaeter AL, Haugen M, Julshamn K, Alexander J, Meltzer HM: Evaluation of urinary iodine excretion as a biomarker for intake of milk and dairy products in pregnant women in the Norwegian Mother and Child Cohort Study (MoBa). Eur J Clin Nutr. 2009 Mar;63(3):347-54. Epub 2007 Dec 5.</reference_text>
                  <pubmed_id>18059417</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
                  <pubmed_id>22494326</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
                  <pubmed_id>23159745</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
                  <pubmed_id>23313728</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
                  <pubmed_id>23535240</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1.</reference_text>
                  <pubmed_id>24704061</pubmed_id>
               </reference>
               <reference>
                  <reference_text>The Merck Manual, 17th ed. Mark H. Beers, MD, Robert Berkow, MD, eds. Whitehouse Station, NJ: Merck Research Labs, 1999.</reference_text>
                  <pubmed_id />
               </reference>
            </references>
         </disease>
         <disease>
            <name>Diabetes mellitus type 2</name>
            <omim_id>125853</omim_id>
            <references>
               <reference>
                  <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
                  <pubmed_id>15899597</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Tasker RC, Lutman D, Peters MJ: Hyperventilation in severe diabetic ketoacidosis. Pediatr Crit Care Med. 2005 Jul;6(4):405-11.</reference_text>
                  <pubmed_id>15982426</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ: Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem. 1984 Mar;30(3):426-32.</reference_text>
                  <pubmed_id>6321058</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Hoppel CL, Genuth SM: Urinary excretion of acetylcarnitine during human diabetic and fasting ketosis. Am J Physiol. 1982 Aug;243(2):E168-72.</reference_text>
                  <pubmed_id>6810706</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Zhang AQ, Mitchell SC, Smith RL: Dimethylamine in human urine. Clin Chim Acta. 1995 Jan 16;233(1-2):81-8.</reference_text>
                  <pubmed_id>7758205</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Blomqvist G, Alvarsson M, Grill V, Von Heijne G, Ingvar M, Thorell JO, Stone-Elander S, Widen L, Ekberg K: Effect of acute hyperketonemia on the cerebral uptake of ketone bodies in nondiabetic subjects and IDDM patients. Am J Physiol Endocrinol Metab. 2002 Jul;283(1):E20-8.</reference_text>
                  <pubmed_id>12067838</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Greco AV, Mingrone G, Capristo E, Benedetti G, De Gaetano A, Gasbarrini G: The metabolic effect of dodecanedioic acid infusion in non-insulin-dependent diabetic patients. Nutrition. 1998 Apr;14(4):351-7.</reference_text>
                  <pubmed_id>9591306</pubmed_id>
               </reference>
               <reference>
                  <reference_text>McLellan AC, Phillips SA, Thornalley PJ: Fluorimetric assay of D-lactate. Anal Biochem. 1992 Oct;206(1):12-6.</reference_text>
                  <pubmed_id>1456422</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Noroozi M, Burns J, Crozier A, Kelly IE, Lean ME: Prediction of dietary flavonol consumption from fasting plasma concentration or urinary excretion. Eur J Clin Nutr. 2000 Feb;54(2):143-9.</reference_text>
                  <pubmed_id>10694785</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Wahl HG, Hoffmann A, Luft D, Liebich HM: Analysis of volatile organic compounds in human urine by headspace gas chromatography-mass spectrometry with a multipurpose sampler. J Chromatogr A. 1999 Jun 25;847(1-2):117-25.</reference_text>
                  <pubmed_id>10431355</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Dungan KM, Buse JB, Largay J, Kelly MM, Button EA, Kato S, Wittlin S: 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care. 2006 Jun;29(6):1214-9.</reference_text>
                  <pubmed_id>16731998</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Costa A, Iguala I, Bedini J, Quinto L, Conget I: Uric acid concentration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabolic syndrome. Metabolism. 2002 Mar;51(3):372-5.</reference_text>
                  <pubmed_id>11887176</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Avogaro A, Bier DM: Contribution of 3-hydroxyisobutyrate to the measurement of 3-hydroxybutyrate in human plasma: comparison of enzymatic and gas-liquid chromatography-mass spectrometry assays in normal and in diabetic subjects. J Lipid Res. 1989 Nov;30(11):1811-7.</reference_text>
                  <pubmed_id>2614280</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, Schwenk WF, Miles JM: Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008 Apr;31(4):643-7. doi: 10.2337/dc07-1683. Epub 2008 Jan 9.</reference_text>
                  <pubmed_id>18184896</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Kawasaki T, Akanuma H, Yamanouchi T: Increased fructose concentrations in blood and urine in patients with diabetes. Diabetes Care. 2002 Feb;25(2):353-7.</reference_text>
                  <pubmed_id>11815509</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Stickle D, Turk J: A kinetic mass balance model for 1,5-anhydroglucitol: applications to monitoring of glycemic control. Am J Physiol. 1997 Oct;273(4 Pt 1):E821-30.</reference_text>
                  <pubmed_id>9357814</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Nguyen TM, Rodriguez LM, Mason KJ, Heptulla RA: Serum 1,5-anhydroglucitol (Glycomark) levels in children with and without type 1 diabetes mellitus. Pediatr Diabetes. 2007 Aug;8(4):214-9.</reference_text>
                  <pubmed_id>17659063</pubmed_id>
               </reference>
               <reference>
                  <reference_text>del Carmen Crespillo M, Olveira G, de Adana MS, Rojo-Martinez G, Garcia-Aleman J, Olvera P, Soriguer F, Munoz A: Metabolic effects of an enteral nutrition formula for diabetes: comparison with standard formulas in patients with type 1 diabetes. Clin Nutr. 2003 Oct;22(5):483-7.</reference_text>
                  <pubmed_id>14512036</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Stupar J, Vrtovec M, Dolinsek F: Longitudinal hair chromium profiles of elderly subjects with normal glucose tolerance and type 2 diabetes mellitus. Metabolism. 2007 Jan;56(1):94-104.</reference_text>
                  <pubmed_id>17161231</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Liebich HM, Buelow HJ, Kallmayer R: Quantification of endogenous aliphatic alcohols in serum and urine. J Chromatogr. 1982 Apr 30;239:343-9.</reference_text>
                  <pubmed_id>7096503</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Shin CS, Moon BS, Park KS, Kim SY, Park SJ, Chung MH, Lee HK: Serum 8-hydroxy-guanine levels are increased in diabetic patients. Diabetes Care. 2001 Apr;24(4):733-7.</reference_text>
                  <pubmed_id>11315839</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Guevara-Aguirre J, Guevara-Aguirre M, Saavedra J, Bernstein G, Rosenbloom AL: Comparison of oral insulin spray and subcutaneous regular insulin at mealtime in type 1 diabetes. Diabetes Technol Ther. 2007 Aug;9(4):372-6.</reference_text>
                  <pubmed_id>17705693</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Giussi GA, Ballejo G, Benedetti WL: Estriol serum levels, neonatal vitality and stromal villous edema in diabetic pregnancies. Acta Diabetol Lat. 1979 Apr-Jun;16(2):105-10.</reference_text>
                  <pubmed_id>484160</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Ostlund RE Jr, McGill JB, Herskowitz I, Kipnis DM, Santiago JV, Sherman WR: D-chiro-inositol metabolism in diabetes mellitus. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9988-92.</reference_text>
                  <pubmed_id>8234346</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Mine S, Okada Y, Kawahara C, Tabata T, Tanaka Y: Serum hyaluronan concentration as a marker of angiopathy in patients with diabetes mellitus. Endocr J. 2006 Dec;53(6):761-6. Epub 2006 Sep 12.</reference_text>
                  <pubmed_id>16966827</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Khuhawar MY, Zardari LA, Laghari AJ: Capillary gas chromatographic determination of methylglyoxal from serum of diabetic patients by precolumn derivatization with 1,2-diamonopropane. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Sep 15;873(1):15-9. doi: 10.1016/j.jchromb.2008.04.048. Epub 2008 May 17.</reference_text>
                  <pubmed_id>18760976</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A: Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Clin Biochem. 2007 Dec;40(18):1398-405. Epub 2007 Aug 10.</reference_text>
                  <pubmed_id>17919531</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, Cheeseman M, Nunez D, Sweatman BC, Haselden JN, Cox RD, Connor SC, Griffin JL: A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics. 2007 Apr 24;29(2):99-108. Epub 2006 Dec 26.</reference_text>
                  <pubmed_id>17190852</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Galli E, Marchini M, Saba A, Berti S, Tonacchera M, Vitti P, Scanlan TS, Iervasi G, Zucchi R: Detection of 3-iodothyronamine in human patients: a preliminary study. J Clin Endocrinol Metab. 2012 Jan;97(1):E69-74. doi: 10.1210/jc.2011-1115. Epub 2011 Oct 26.</reference_text>
                  <pubmed_id>22031514</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Llorach R, Urpi-Sarda M, Tulipani S, Garcia-Aloy M, Monagas M, Andres-Lacueva C: Metabolomic fingerprint in patients at high risk of cardiovascular disease by cocoa intervention. Mol Nutr Food Res. 2013 Jun;57(6):962-73. doi: 10.1002/mnfr.201200736. Epub 2013  May 2.</reference_text>
                  <pubmed_id>23637065</pubmed_id>
               </reference>
               <reference>
                  <reference_text>World Health Organisation Department of Noncommunicable Disease Surveillance (1999). "Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications"</reference_text>
                  <pubmed_id />
               </reference>
               <reference>
                  <reference_text>Rosa Va Ìzquez-Fresno et al. An NMR metabolomics approach reveals a combined-biomarkers model in a wine interventional trial with validation in free-living individuals of the PREDIMED study.  Metabolomics (2015) 11:797- 806: https://link.springer.com/content/pdf/10.1007/s11306-014-0735-x.pdf</reference_text>
               </reference>
            </references>
         </disease>
         <disease>
            <name>Kidney disease</name>
            <omim_id />
            <references>
               <reference>
                  <reference_text>Galley HF, Le Cras AE, Yassen K, Grant IS, Webster NR: Circulating tetrahydrobiopterin concentrations in patients with septic shock. Br J Anaesth. 2001 Apr;86(4):578-80.</reference_text>
                  <pubmed_id>11573638</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Yokoyama K, Tajima M, Yoshida H, Nakayama M, Tokutome G, Sakagami H, Hosoya T: Plasma pteridine concentrations in patients with chronic renal failure. Nephrol Dial Transplant. 2002 Jun;17(6):1032-6.</reference_text>
                  <pubmed_id>12032193</pubmed_id>
               </reference>
               <reference>
                  <reference_text>McGregor DO, Dellow WJ, Lever M, George PM, Robson RA, Chambers ST: Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations. Kidney Int. 2001 Jun;59(6):2267-72.</reference_text>
                  <pubmed_id>11380830</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Ehrenpreis ED, Salvino M, Craig RM: Improving the serum D-xylose test for the identification of patients with small intestinal malabsorption. J Clin Gastroenterol. 2001 Jul;33(1):36-40.</reference_text>
                  <pubmed_id>11418788</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Niwa T, Takeda N, Yoshizumi H: RNA metabolism in uremic patients: accumulation of modified ribonucleosides in uremic serum. Technical note. Kidney Int. 1998 Jun;53(6):1801-6.</reference_text>
                  <pubmed_id>9607216</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Jankowski J, van der Giet M, Jankowski V, Schmidt S, Hemeier M, Mahn B, Giebing G, Tolle M, Luftmann H, Schluter H, Zidek W, Tepel M: Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. J Clin Invest. 2003 Jul;112(2):256-64.</reference_text>
                  <pubmed_id>12865413</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Gill DS, Fonseca VA, Barradas MA, Balliod R, Moorhead JF, Dandona P: Plasma histamine in patients with chronic renal failure and nephrotic syndrome. J Clin Pathol. 1991 Mar;44(3):243-5.</reference_text>
                  <pubmed_id>2013627</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Fleck C, Schweitzer F, Karge E, Busch M, Stein G: Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases. Clin Chim Acta. 2003 Oct;336(1-2):1-12.</reference_text>
                  <pubmed_id>14500028</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Bain MA, Faull R, Fornasini G, Milne RW, Evans AM: Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis. Nephrol Dial Transplant. 2006 May;21(5):1300-4. Epub 2006 Jan 9.</reference_text>
                  <pubmed_id>16401621</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Teerlink T, Hennekes MW, Mulder C, Brulez HF: Determination of dimethylamine in biological samples by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 1997 Apr 11;691(2):269-76.</reference_text>
                  <pubmed_id>9174262</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Takagi T, Chung TG, Saito A: Determination of polyamines in hydrolysates of uremic plasma by high-performance cation-exchange column chromatography. J Chromatogr. 1983 Feb 11;272(2):279-85.</reference_text>
                  <pubmed_id>6833425</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Burke RA, Moberly JB, Patel H, Shockley TR, Martis L: Maltose and isomaltose in uremic plasma following icodextrin administration. Adv Perit Dial. 1998;14:120-3.</reference_text>
                  <pubmed_id>10649708</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Liebich HM, Woll J: Volatile substances in blood serum: profile analysis and quantitative determination. J Chromatogr. 1977 Nov 11;142:505-16.</reference_text>
                  <pubmed_id>914932</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Raj DS, Ouwendyk M, Francoeur R, Pierratos A: Plasma amino acid profile on nocturnal hemodialysis. Blood Purif. 2000;18(2):97-102.</reference_text>
                  <pubmed_id>10838467</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Paniagua R, Claure R, Amato D, Flores E, Perez A, Exaire E: Effects of oral administration of zinc and diiodohydroxyquinolein on plasma zinc levels of uremic patients. Nephron. 1995;69(2):147-50.</reference_text>
                  <pubmed_id>7723896</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Chuang CK, Lin SP, Chen HH, Chen YC, Wang TJ, Shieh WH, Wu CJ: Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis. Clin Chim Acta. 2006 Feb;364(1-2):209-16. Epub 2005 Aug 8.</reference_text>
                  <pubmed_id>16087168</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Butscheid M, Schafer C, Brenner S, Alscher D, Murdter T, Niwa T, Frischmann M, Pischetsrieder M, Klotz U: Unchanged serum levels of advanced glycation endproducts in patients with liver disease. Naunyn Schmiedebergs Arch Pharmacol. 2007 Aug;375(6):401-6. Epub 2007 Jun 15.</reference_text>
                  <pubmed_id>17571253</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Stenvinkel P, Rodriguez-Ayala E, Massy ZA, Qureshi AR, Barany P, Fellstrom B, Heimburger O, Lindholm B, Alvestrand A: Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2006 Mar;1(2):281-7. Epub 2006 Feb 1.</reference_text>
                  <pubmed_id>17699218</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Bain MA, Faull R, Milne RW, Evans AM: Oral L-carnitine: metabolite formation and hemodialysis. Curr Drug Metab. 2006 Oct;7(7):811-6.</reference_text>
                  <pubmed_id>17073580</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A: Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Clin Biochem. 2007 Dec;40(18):1398-405. Epub 2007 Aug 10.</reference_text>
                  <pubmed_id>17919531</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Nieren- und Hochdruckkrankheiten (1978), 7(2), 62-74 (translated from German Kidney and Hypertension).</reference_text>
                  <pubmed_id />
               </reference>
            </references>
         </disease>
         <disease>
            <name>Maple syrup urine disease</name>
            <omim_id>248600</omim_id>
            <references>
               <reference>
                  <reference_text>Shigematsu Y, Kikuchi K, Momoi T, Sudo M, Kikawa Y, Nosaka K, Kuriyama M, Haruki S, Sanada K, Hamano N, et al.: Organic acids and branched-chain amino acids in body fluids before and after multiple exchange transfusions in maple syrup urine disease. J Inherit Metab Dis. 1983;6(4):183-9.</reference_text>
                  <pubmed_id>6422161</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Deng C, Shang C, Hu Y, Zhang X: Rapid diagnosis of phenylketonuria and other aminoacidemias by quantitative analysis of amino acids in neonatal blood spots by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jul 25;775(1):115-20.</reference_text>
                  <pubmed_id>12101068</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Schadewaldt P, Bodner-Leidecker A, Hammen HW, Wendel U: Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease. Clin Chem. 1999 Oct;45(10):1734-40.</reference_text>
                  <pubmed_id>10508118</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Schadewaldt P, Hammen HW, Ott AC, Wendel U: Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease. J Inherit Metab Dis. 1999 Aug;22(6):706-22.</reference_text>
                  <pubmed_id>10472531</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Kumps A, Duez P, Mardens Y: Metabolic, nutritional, iatrogenic, and artifactual sources of urinary organic acids: a comprehensive table. Clin Chem. 2002 May;48(5):708-17.</reference_text>
                  <pubmed_id>11978597</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Gronwald W, Klein MS, Kaspar H, Fagerer SR, Nurnberger N, Dettmer K, Bertsch T, Oefner PJ: Urinary metabolite quantification employing 2D NMR spectroscopy. Anal Chem. 2008 Dec 1;80(23):9288-97. doi: 10.1021/ac801627c.</reference_text>
                  <pubmed_id>19551947</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Podebrad F, Heil M, Reichert S, Mosandl A, Sewell AC, Bohles H: 4,5-dimethyl-3-hydroxy-2[5H]-furanone (sotolone)--the odour of maple syrup urine disease. J Inherit Metab Dis. 1999 Apr;22(2):107-14.</reference_text>
                  <pubmed_id>10234605</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Yunus ZM, Kamaludin DA, Mamat M, Choy YS, Ngu L: Clinical and biochemical profiles of maple syrup urine disease in malaysian children. JIMD Rep. 2012;5:99-107. doi: 10.1007/8904_2011_105. Epub 2011 Dec 11.</reference_text>
                  <pubmed_id>23430924</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Barschak AG, Marchesan C, Sitta A, Deon M, Giugliani R, Wajner M, Vargas CR: Maple syrup urine disease in treated patients: biochemical and oxidative stress profiles. Clin Biochem. 2008 Mar;41(4-5):317-24. Epub 2007 Dec 5.</reference_text>
                  <pubmed_id>18088602</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Peritoneal dialysis in maple-syrup-urine disease: Studies on branched-chain amino and keto acids. Eur J Pediatr (1980) 134: 57. https://doi.org/10.1007/BF00442404</reference_text>
                  <pubmed_id />
               </reference>
               <reference>
                  <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
                  <pubmed_id />
               </reference>
            </references>
         </disease>
         <disease>
            <name>Obesity</name>
            <omim_id>601665</omim_id>
            <references>
               <reference>
                  <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
                  <pubmed_id>15899597</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Serlie MJ, Meijer AJ, Groener JE, Duran M, Endert E, Fliers E, Aerts JM, Sauerwein HP: Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects. J Clin Endocrinol Metab. 2007 Apr;92(4):1524-9. Epub 2007 Jan 30.</reference_text>
                  <pubmed_id>17264178</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Vice E, Privette JD, Hickner RC, Barakat HA: Ketone body metabolism in lean and obese women. Metabolism. 2005 Nov;54(11):1542-5.</reference_text>
                  <pubmed_id>16253646</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Brind J, Strain G, Miller L, Zumoff B, Vogelman J, Orentreich N: Obese men have elevated plasma levels of estrone sulfate. Int J Obes. 1990 Jun;14(6):483-6.</reference_text>
                  <pubmed_id>2401584</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Driskell JA, Chrisley BM, Reynolds LK, Moak SW: Plasma B6 vitamer and plasma and urinary 4-pyridoxic acid concentrations of middle-aged obese black women. J Chromatogr. 1991 Aug 23;568(2):333-40.</reference_text>
                  <pubmed_id>1783639</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Haro C, Montes-Borrego M, Rangel-Zuniga OA, Alcala-Diaz JF, Gomez-Delgado F, Perez-Martinez P, Delgado-Lista J, Quintana-Navarro GM, Tinahones FJ, Landa BB, Lopez-Miranda J, Camargo A, Perez-Jimenez F: Two Healthy Diets Modulate Gut Microbial Community Improving Insulin Sensitivity in a Human Obese Population. J Clin Endocrinol Metab. 2016 Jan;101(1):233-42. doi: 10.1210/jc.2015-3351. Epub  2015 Oct 27.</reference_text>
                  <pubmed_id>26505825</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Vioque J, Weinbrenner T, Asensio L, Castello A, Young IS, Fletcher A: Plasma concentrations of carotenoids and vitamin C are better correlated with dietary intake in normal weight than overweight and obese elderly subjects. Br J Nutr. 2007 May;97(5):977-86.</reference_text>
                  <pubmed_id>17408529</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Burrows TL, Warren JM, Colyvas K, Garg ML, Collins CE: Validation of overweight children's fruit and vegetable intake using plasma carotenoids. Obesity (Silver Spring). 2009 Jan;17(1):162-8. doi: 10.1038/oby.2008.495. Epub 2008 Nov 6.</reference_text>
                  <pubmed_id>18997681</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Reinehr T, Wolters B, Knop C, Lass N, Hellmuth C, Harder U, Peissner W, Wahl S, Grallert H, Adamski J, Illig T, Prehn C, Yu Z, Wang-Sattler R, Koletzko B: Changes in the serum metabolite profile in obese children with weight loss. Eur J Nutr. 2015 Mar;54(2):173-81. doi: 10.1007/s00394-014-0698-8. Epub 2014 Apr  17.</reference_text>
                  <pubmed_id>24740590</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Wahl S, Yu Z, Kleber M, Singmann P, Holzapfel C, He Y, Mittelstrass K, Polonikov A, Prehn C, Romisch-Margl W, Adamski J, Suhre K, Grallert H, Illig T, Wang-Sattler R, Reinehr T: Childhood obesity is associated with changes in the serum metabolite profile. Obes Facts. 2012;5(5):660-70. doi: 10.1159/000343204. Epub 2012 Oct 4.</reference_text>
                  <pubmed_id>23108202</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Cho K, Moon JS, Kang JH, Jang HB, Lee HJ, Park SI, Yu KS, Cho JY: Combined untargeted and targeted metabolomic profiling reveals urinary biomarkers for discriminating obese from normal-weight adolescents. Pediatr Obes. 2017 Apr;12(2):93-101. doi: 10.1111/ijpo.12114. Epub 2016 Feb 22.</reference_text>
                  <pubmed_id>26910390</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Metabolomics reveals determinants of weight loss during lifestyle intervention in obese children</reference_text>
                  <pubmed_id />
               </reference>
            </references>
         </disease>
         <disease>
            <name>Propionic acidemia</name>
            <omim_id>606054</omim_id>
            <references>
               <reference>
                  <reference_text>Scholl-Burgi S, Haberlandt E, Gotwald T, Albrecht U, Baumgartner Sigl S, Rauchenzauner M, Rostasy K, Karall D: Stroke-like episodes in propionic acidemia caused by central focal metabolic decompensation. Neuropediatrics. 2009 Apr;40(2):76-81. doi: 10.1055/s-0029-1231065. Epub 2009 Oct 6.</reference_text>
                  <pubmed_id>19809936</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Gronwald W, Klein MS, Kaspar H, Fagerer SR, Nurnberger N, Dettmer K, Bertsch T, Oefner PJ: Urinary metabolite quantification employing 2D NMR spectroscopy. Anal Chem. 2008 Dec 1;80(23):9288-97. doi: 10.1021/ac801627c.</reference_text>
                  <pubmed_id>19551947</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Thompson GN, Chalmers RA, Walter JH, Bresson JL, Lyonnet SL, Reed PJ, Saudubray JM, Leonard JV, Halliday D: The use of metronidazole in management of methylmalonic and propionic acidaemias. Eur J Pediatr. 1990 Aug;149(11):792-6.</reference_text>
                  <pubmed_id>2226555</pubmed_id>
               </reference>
               <reference>
                  <reference_text>Riemersma M, Hazebroek MR, Helderman-van den Enden ATJM, Salomons GS, Ferdinandusse S, Brouwers MCGJ, van der Ploeg L, Heymans S, Glatz JFC, van den Wijngaard A, Krapels IPC, Bierau J, Brunner HG: Propionic acidemia as a cause of adult-onset dilated cardiomyopathy. Eur J Hum Genet. 2017 Nov;25(11):1195-1201. doi: 10.1038/ejhg.2017.127. Epub 2017 Aug 30.</reference_text>
                  <pubmed_id>28853722</pubmed_id>
               </reference>
               <reference>
                  <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
                  <pubmed_id />
               </reference>
            </references>
         </disease>
         <disease>
            <name>Eosinophilic esophagitis</name>
            <omim_id>610247</omim_id>
            <references>
               <reference>
                  <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
                  <pubmed_id />
               </reference>
            </references>
         </disease>
         <disease>
            <name>Early preeclampsia</name>
            <omim_id />
            <references>
               <reference>
                  <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
                  <pubmed_id>22494326</pubmed_id>
               </reference>
            </references>
         </disease>
         <disease>
            <name>Late-onset preeclampsia</name>
            <omim_id />
            <references>
               <reference>
                  <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
                  <pubmed_id>23159745</pubmed_id>
               </reference>
            </references>
         </disease>
      </diseases>
      <drugbank_id />
      <drugbank_metabolite_id />
      <phenol_explorer_compound_id />
      <phenol_explorer_metabolite_id />
      <foodb_id>FDB012119</foodb_id>
      <knapsack_id />
      <chemspider_id>83153</chemspider_id>
      <kegg_id>C01152</kegg_id>
      <biocyc_id>CPD-1823</biocyc_id>
      <bigg_id />
      <wikipidia />
      <nugowiki>1</nugowiki>
      <metagene />
      <metlin_id>3741</metlin_id>
      <pubchem_compound_id>92105</pubchem_compound_id>
      <het_id>HIC</het_id>
      <chebi_id>50599</chebi_id>
      <synthesis_reference>Jain, Rahul; Cohen, Louis A. Regiospecific alkylation of histidine and histamine at N-1 (t).Tetrahedron  (1996),  52(15),  5363-70.</synthesis_reference>
      <general_references>
         <reference>
            <reference_text>Colombani PC, Kovacs E, Frey-Rindova P, Frey W, Langhans W, Arnold M, Wenk C: Metabolic effects of a protein-supplemented carbohydrate drink in marathon runners. Int J Sport Nutr. 1999 Jun;9(2):181-201.</reference_text>
            <pubmed_id>10362454</pubmed_id>
         </reference>
         <reference>
            <reference_text>Nicholson JK, Foxall PJ, Spraul M, Farrant RD, Lindon JC: 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal Chem. 1995 Mar 1;67(5):793-811.</reference_text>
            <pubmed_id>7762816</pubmed_id>
         </reference>
         <reference>
            <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
            <pubmed_id>11052553</pubmed_id>
         </reference>
         <reference>
            <reference_text>Giesecke K, Magnusson I, Ahlberg M, Hagenfeldt L, Wahren J: Protein and amino acid metabolism during early starvation as reflected by excretion of urea and methylhistidines. Metabolism. 1989 Dec;38(12):1196-200.</reference_text>
            <pubmed_id>2593832</pubmed_id>
         </reference>
         <reference>
            <reference_text>Vranic L, Granic P, Rajic Z: Basic amino acid in the pathogenesis of caries. Acta Stomatol Croat. 1991;25(2):71-6.</reference_text>
            <pubmed_id>1819935</pubmed_id>
         </reference>
         <reference>
            <reference_text>Sjolin J, Stjernstrom H, Henneberg S, Hambraeus L, Friman G: Evaluation of urinary 3-methylhistidine excretion in infection by measurements of 1-methylhistidine and the creatinine ratios. Am J Clin Nutr. 1989 Jan;49(1):62-70.</reference_text>
            <pubmed_id>2912013</pubmed_id>
         </reference>
         <reference>
            <reference_text>COCKS DH, DENNIS PO, NELSON TH: ISOLATION OF 3-METHYL HISTIDINE FROM WHALEMEAT EXTRACT AND THE PREPARATION OF SOME DERIVATIVES. Nature. 1964 Apr 11;202:184-5.</reference_text>
            <pubmed_id>14156296</pubmed_id>
         </reference>
         <reference>
            <reference_text>Dohm GL, Williams RT, Kasperek GJ, van Rij AM: Increased excretion of urea and N tau -methylhistidine by rats and humans after a bout of exercise. J Appl Physiol Respir Environ Exerc Physiol. 1982 Jan;52(1):27-33.</reference_text>
            <pubmed_id>7061274</pubmed_id>
         </reference>
         <reference>
            <reference_text>Garlick PJ, McNurlan MA, Bark T, Lang CH, Gelato MC: Hormonal regulation of protein metabolism in relation to nutrition and disease. J Nutr. 1998 Feb;128(2 Suppl):356S-359S.</reference_text>
            <pubmed_id>9478024</pubmed_id>
         </reference>
         <reference>
            <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
            <pubmed_id>15899597</pubmed_id>
         </reference>
         <reference>
            <reference_text>Dunnett M, Harris RC: High-performance liquid chromatographic determination of imidazole dipeptides, histidine, 1-methylhistidine and 3-methylhistidine in equine and camel muscle and individual muscle fibres. J Chromatogr B Biomed Sci Appl. 1997 Jan 10;688(1):47-55.</reference_text>
            <pubmed_id>9029312</pubmed_id>
         </reference>
         <reference>
            <reference_text>Betto P, Ricciarello G, Pichini S, Dello Strologo L, Rizzoni G: High-performance liquid chromatography-electrochemical detection of 3-methylhistidine in human urine. J Chromatogr. 1992 Dec 23;584(2):256-60.</reference_text>
            <pubmed_id>1484110</pubmed_id>
         </reference>
      </general_references>
      <protein_associations>
         <protein>
            <protein_accession>HMDBP00473</protein_accession>
            <name>Beta-Ala-His dipeptidase</name>
            <uniprot_id>Q96KN2</uniprot_id>
            <gene_name>CNDP1</gene_name>
            <protein_type>Unknown</protein_type>
         </protein>
         <protein>
            <protein_accession>HMDBP00474</protein_accession>
            <name>Protein arginine N-methyltransferase 3</name>
            <uniprot_id>O60678</uniprot_id>
            <gene_name>PRMT3</gene_name>
            <protein_type>Unknown</protein_type>
         </protein>
      </protein_associations>
   </metabolite>
</hmdb>